Pharma Mar (Spain) Today
| PHM Stock | EUR 77.00 1.50 1.99% |
Performance18 of 100
| Odds Of DistressLess than 9
|
Pharma Mar is trading at 77.00 as of the 28th of November 2024, a 1.99% up since the beginning of the trading day. The stock's open price was 75.5. Pharma Mar has less than a 9 % chance of experiencing financial distress in the next few years and had a solid performance during the last 90 days. Equity ratings for Pharma Mar SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of December 2022 and ending today, the 28th of November 2024. Click here to learn more.
Pharma Mar, S.A., a biopharmaceutical company, engages in the discovery and development of marine-derived anticancer drugs in Spain and internationally. Pharma Mar, S.A. was founded in 1986 and is based in Madrid, Spain. PHARMA MAR operates under Biotechnology classification in Spain and is traded on Madrid SE C.A.T.S.. The company has 18.09 M outstanding shares. More on Pharma Mar SA
Moving against Pharma Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Pharma Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Pharma Mar's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Pharma Mar or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Pharma Mar SA (PHM) is traded on Madrid Exchange in Spain and employs 477 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.09 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pharma Mar's market, we take the total number of its shares issued and multiply it by Pharma Mar's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Pharma Mar SA operates under Healthcare sector and is part of Biotechnology industry. The entity has 18.09 M outstanding shares.
Pharma Mar SA has accumulated about 42.72 M in cash with 25.68 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19.
Check Pharma Mar Probability Of Bankruptcy
Ownership AllocationPharma Mar owns a total of 18.09 Million outstanding shares. Pharma Mar has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Pharma Ownership Details
Pharma Mar SA Risk Profiles
Although Pharma Mar's alpha and beta are two of the key measurements used to evaluate Pharma Mar's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.06 | |||
| Semi Deviation | 1.35 | |||
| Standard Deviation | 4.49 | |||
| Variance | 20.13 |
Pharma Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Pharma Mar without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
Pharma Mar Corporate Management
Elected by the shareholders, the Pharma Mar's board of directors comprises two types of representatives: Pharma Mar inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pharma. The board's role is to monitor Pharma Mar's management team and ensure that shareholders' interests are well served. Pharma Mar's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pharma Mar's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pedro Puentes | Ex ViceChairman | Profile | |
| Jose SousaFaro | Ex Founder | Profile | |
| Sandra Sanchez | Global Head | Profile | |
| Elena Crespo | Director Admin | Profile | |
| Jos MartinezLosa | Director Relations | Profile | |
| Mara Caballero | Chief Officer | Profile | |
| Juan Nogues | Director Sales | Profile |
Other Information on Investing in Pharma Stock
Pharma Mar financial ratios help investors to determine whether Pharma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharma with respect to the benefits of owning Pharma Mar security.